Manfredi Roberto, Sabbatani Sergio, Calza Leonardo, Chiodo Francesco
Department of Clinical and Experimental Medicine, Division of Infectious Diseases, University of Bologna Alma Mater Studiorum, S. Orsola Hospital, Bologna, Italy.
Scand J Infect Dis. 2006;38(6-7):566-70. doi: 10.1080/00365540500434653.
Two very rare case reports of bladder transitional cell carcinoma associated with HIV infection in patients treated with combined antiretroviral therapy are described, and discussed on the ground of the most relevant and updated literature resources. Only 13 cases of vesical carcinoma have been reported to date in the setting of HIV infection, but only 3 anecdotal single reports (the last in the y 2001) described clinical, therapeutic, and outcome issues of this rare disease association in some detail. In our patients, micro- or macro-haematuria was the clue for in-depth diagnosis and prompt treatment, which was limited to multiple local interventions in 1 case, but finally required a radical cystectomy in the second patient. No relationship was found with the very favourable underlying HIV-related virological and immunological status, and the present 8-12-month follow-up did not show disease relapses.
本文描述了两例接受联合抗逆转录病毒治疗的患者中,膀胱移行细胞癌与HIV感染相关的极为罕见的病例报告,并依据最相关和最新的文献资源进行了讨论。迄今为止,在HIV感染背景下仅报告了13例膀胱癌病例,但仅有3篇轶事性单病例报告(最后一篇发表于2001年)较为详细地描述了这种罕见疾病关联的临床、治疗及预后问题。在我们的患者中,镜下或肉眼血尿是深入诊断和及时治疗的线索,其中1例患者的治疗仅限于多次局部干预,但第二例患者最终需要进行根治性膀胱切除术。未发现与潜在的非常良好的HIV相关病毒学和免疫学状态存在关联,目前8至12个月的随访未显示疾病复发。